Abstract
Purpose
This study aimed to explore physicians’ use of drug information in professional work, with special focus on those working in primary care, and also in relation to personal characteristics of physicians.
Methods
A web-based questionnaire was distributed by e-mail to physicians in five regions in Sweden. The questions concerned drug-related queries at issue when searching for information, sources used, and factors of importance for the choice of source, as well as responder characteristics.
Results
A total of 3254 (85%) out of 3814 responding physicians stated that they searched for drug information every week. For physicians working in primary health care, the corresponding number was 585 (96%). The most common drug-related issues searched for by 76% of physicians every week concerned pharmacotherapeutic aspects (e.g., dosing), followed by adverse drug reactions (63%). For 3349 (88%) physicians, credibility was the most important factor for the choice of sources of drug information, followed by easy access online (n = 3127, 82%). Further analyses among physicians in primary care showed that some personal characteristics, like seniority, sex, and country of education, as well as research experience, were associated with usage and preferences of drug information sources.
Conclusions
This study confirms that physicians often use drug information sources in professional work, in particular those who work in primary health care. Credibility and easy access are key factors for usage. Among physicians in primary care, personal factors influenced the choice of drug information sources.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Background
Prescribing medicines shall be based on scientific knowledge and proven experience. To facilitate the process of prescribing, numerous sources can be searched for drug information. Indeed, a systematic review found that treatment was the first-ranked physician clinical information needed in most articles [1]. A literature review 3 decades ago suggested that commercial sources (direct mail, journal advertising, and detailing) had declined significantly in importance as sources of pharmaceutical information, whereas colleagues and conferences/conventions had increased [2]. Since then, over the last 3 decades, physicians’ usage of health information has changed dramatically. Online health information has also become part of daily work, necessitating digital skills. As information sources vary over time, revisiting the use of drug information sources in current health care is warranted. As physicians in primary care treat patients over all disciplines, knowledge about information sources used in that context could be of particular interest [3].
Information seeking behavior of physicians seems to depend on a variety of factors. Although many studies have focused on technical and organizational factors [1], there are a few studies implying that personal factors could have an impact on information seeking behaviors [2, 4]. Therefore, there is a need for knowledge on the usage of drug information among physicians, especially in relation to their personal characteristics. The aim of this descriptive study was to investigate physicians’ use of drug information in professional work, with special focus on those working in primary care. A second purpose was to explore a possible association between personal characteristics of primary care physicians and their choices of sources of drug information.
Methods
Study population
The study involved physicians active in five Swedish regions (Region Västerbotten, Region Västernorrland, Region Östergötland, Region Jönköping County, and Region Västra Götaland). A link to a web-based anonymous questionnaire was distributed by e-mail to all physicians with an available e-mail address (n = 12,011) in the study regions. E-mail addresses were obtained from the regional administrative units. The response rate was 32.8% (n = 3944). Of the participating physicians, 130 did not state any medical specialty for their place of work and were excluded from further analysis due to uncertainty if they were active. Consequently, 3814 physicians active in a total of 66 different medical specialties were included in the study. In addition, the largest individual specialty, physicians working in primary health care (n = 609), which constituted 14% of the whole study population, was analyzed separately with respect to possible associations with responder characteristics (Fig. 1).
Questionnaire and collection of data
The questionnaire contained two sections, concerning (i) drug-related queries and type of drugs at issue when searching for information, sources used, and factors of importance for the choice of source, and (ii) responder characteristics, including age, sex, position, specialty, and extent of patient work. Predefined answer alternatives were provided as well as free text options. For some questions, the respondents could select multiple answers. It was not mandatory to respond to all questions. For validation purposes, the questionnaire was piloted in a group of physicians in a primary health care center in Umeå. A web-based tool for surveys and analysis was used to distribute the questionnaires (esMaker version NX2, Entergate AB, Sweden). In all, eleven reminders were sent. The recipients could actively choose not to get more reminders by entering a code in the e-mail.
Statistics
All statistical analyses were conducted using SPSS version 25 (IBM Corp., Armonk, NY, USA). The dichotomized variables are presented in numbers (n) and percentages (%). The group of physicians active in other specialties than primary care was a very heterogeneous group, since some medical specialties use medical drugs to a greater extent, e.g., geriatrics, and others to a much lesser extent, e.g., hand surgery. With that in regard, no statistical comparisons were performed between the whole group of physicians and physicians active in primary care. To test possible associations between responder characteristics and preferences of drug information sources, we focused on physicians active in primary care. Pearson chi-square test was used, and Bonferroni correction was applied to adjust for multiple comparisons. Statistical significance was set at α = 0.05 (two sided).
Ethics
The Swedish Ethical Review Authority determined that the Ethics Review Act was not applicable to this study and had no objections to the performance of the study (ref 2016/157–31). The respondents of the questionnaire stayed anonymous by automatic coding of the questionnaires within esMaker. Thus, no one, including the researchers, could link participants’ responses with their identity.
Results
Characteristics of the responding physicians are shown in Table 1. A total of 3254 (85%) out of 3814 respondents in the study reported searching for information about drugs at least every week. In the subgroup of physicians working in primary care, the corresponding figure was 585 (96%). For physicians 50 years and younger, compared with those above 50 years of age, the proportions were 89% versus 76% (p < 0.001). The most common drug-related issues searched for by 2888 (76%) physicians every week concerned pharmacotherapeutic aspects (e.g., dosing), followed by adverse drug reactions searched for by 2384 (63%) physicians (Table 2). The various types of drug-related issues were encountered in the same mutual order for both groups of physicians. A total of 558 (15%) respondents chose to list at least one drug-related issue in free text, most commonly regarding pharmacodynamics and pricing of drugs (each n = 63, 1.7%).
The Pharmaceutical Specialties Inc. in Sweden was the source of drug information that almost all physicians reported using frequently (94%), followed by national online knowledge compilations (64%) (Table 2). Pharmaceutical Specialties in Sweden is integrated into all Swedish healthcare systems and contain electronic product information, including a Summary of Product Characteristics. In addition, among physicians in primary care, the regional drug and therapeutics committee, including regional prescribing guidelines, was a frequently used source of drug information (51%). Given the opportunity to list other sources of drug information not predefined in the questionnaire, 97 respondents (2.5%) reported that they frequently use the web-based decision support source UpToDate. Credibility was the most important factor for the choice of sources of drug information for 88% of the physicians, followed by easy access online, selected by 80% of physicians (Table 2).
Antibiotics were the group of drugs most often at issue in search of information (84%) (Table 3). For all drug groups except for antiepileptics and anticancer drugs, a larger proportion of physicians working in primary care stated that they often sought information compared with the entire group of physicians.
The questionnaire also contained questions concerning the type and provider of oral drug information at the physicians’ workplace. Overall, the physicians responded that the information most frequently concerned a specific drug (n = 2081, 65%). For physicians working in primary care, the corresponding number was lower, n = 274 (45%). Regarding the provider of drug information, a total of 2641 (69%) physicians responded that the information usually was given by representatives from pharmaceutical companies. For physicians in primary care, the corresponding number was 321 (53%). A total of 244 (6.4%) physicians and 154 (25%) physicians working in primary care, reported that the drug information mostly was provided by representatives from the public regions. About a quarter of the respondents reported that they never received any drug information at all at their workplace; n = 997 (26%) for the whole group of physicians and n = 146 (24%) for physicians working in primary care.
In a more detailed analysis among physicians working in primary care, several responder characteristics were associated with usage of, as well as preferences of, drug information sources (Table 4). Overall juniority, i.e., status as a junior doctor and age 50 years and younger, was associated with more frequent use of drug information. The significant difference between men and women regarding the usage of information about drugs in pregnancy remained even after division by professional status.
Discussion
The present study, covering five regions in Sweden and, to the best of our knowledge, the largest study hitherto performed, confirms physicians’ need for drug information. It appears that physicians use multiple sources in the search for several drug-related issues, including, for example, dosing, adverse drug reactions, drug choices, and drug interactions. Furthermore, credibility, easy online access, familiarity, update frequency, and knowledge of origin or author seem to be crucial for their choice of drug information source. In addition, we found several personal factors associated with physicians’ choice of information sources.
Most of the physicians in our study searched for information about drugs at least weekly. Since drug dosing errors [5] and adverse drug reactions [6, 7] both are frequently occurring in health care, the finding of pharmacotherapy including dosing as the most common drug-related issue for searching and adverse effects as the next most common may be reassuring.
There was a similar pattern for physicians in primary care as for physicians active in other specialties with respect to the most commonly used sources for drug information, i.e., Pharmaceutical Specialties Inc. in Sweden as well as national online knowledge compilations. Our result that colleagues are an important source of information is consistent with two prior studies, both published in 2013 [8, 9]. However, asking a colleague was considerably less common in a study from Ireland, published in 2001, where 7% of general practitioners (GPs) and 29% of hospital doctors consulted colleagues for prescribing information [4].
In our study, the most conspicuous difference in the usage of sources of information between physicians active in primary care and physicians active in other specialties was that the former used information from the regional drug and therapeutic committee, e.g., regional prescribing guidelines, to a greater extent and PubMed and webpages of specialist associations to a smaller extent. These results may not be surprising. Indeed, regional prescribing guidelines are intended for physicians in primary care. A previous questionnaire study among 603 Swedish physicians in 2008 in primary care revealed that 97% used these guidelines [10], and in general, specialist associations do not focus on primary care.
Notably, about one-third of all physicians frequently use the search engine Google when searching for drug information. This is consistent with results from other studies that report high use of non-authoritative sources, including Google [11,12,13]. A descriptive survey including 444 randomly selected physicians in Nigeria, published in 2011, reported Google being the most frequently used search engine (73%), and PubMed being the most used medical database (70%) [11]. In a study from 2015 among medical residents in New Jersey, 56% reported using Google on mobile devices. However, that study reported that Google was primarily used to identify foreign drugs and only by 2.7% for questions regarding dosing [12]. The use of non-authoritative online information sources such as Google implies that the prescriber needs to be able to differentiate between reliable and non-reliable sources. In this context, it should be noted that a minority of our respondents had a PhD degree, and furthermore, a majority had no research experience at all. Nevertheless, 88% stated that credibility was the most important factor when choosing sources of drug information. This may imply that they find it important to evaluate reliability of information sources. This is consistent with a systematic review where credibility was one of five listed factors that could have significant effects on physicians’ choices of information sources [1].
In our study, there was a difference in who provides doctors with oral drug information at work. In the previously mentioned Irish study, the GPs reported consulting the pharmaceutical industry to a greater extent (42%) than the hospital doctors (18%) before prescribing a new drug [4]. In another previous Swedish study from 2011, about 85% of the GPs responding to a questionnaire reported getting too much information from the pharmaceutical industry [14]. In contrast, physicians in primary care in our study stated to a greater extent that the information was provided by representatives employed in the regions, while physicians in specialist care stated that the information came to a greater extent from the pharmaceutical companies. This could have implications for prescribing since a previous study published in 2010 showed that the presence of drug information from the pharmaceutical industry was negatively associated with adherence to the prescribing objectives [15]. It was also notable that about one-quarter of our respondents stated that they do not receive any information at all about drugs at their workplace, since prescribing drugs is an important professional activity for physicians that requires continuous updating.
In a study from Ethiopia published in 2013, respondents from a specialized hospital were more likely to consult drug information sources compared with respondents from primary care [16]. In our study, the relationship was reversed. Of physicians in primary care, 96% reported searching for information about drugs at least every week, compared with 83% for physicians active in specialties others than primary health care. This difference between our study and the previous one may reflect the extensive availability of drug information in primary care in a developed country compared to a developing country. Indeed, most of our respondents from primary care had searched for information over the last 6 months for the majority of the predefined groups of drugs. This seems logical since physicians in primary care meet patients with varying diseases, including older people with multiple morbidities.
Among physicians in primary care, we found that professional status as a junior doctor, as well as younger age, was associated with more frequent use of drug information in general. This finding is in line with a study from 2012 in which 721 French GPs answered a questionnaire about using the Internet for clinical information [17]. In addition, professional status as a junior doctor and younger age were, in our study, also associated with advice taken from colleagues. Interestingly, female primary care physicians more often used colleagues as a source of information and also found sources recommended by colleagues more reliable. This result is consistent with a previous study from Denmark, published in 2016, where young and female GPs were more likely to seek information from colleagues [18]. Unexpectedly, male physicians in primary care sought a greater extent of information about drugs in pregnancy compared with their female counterparts. Finally, our results of more extensive use of PubMed for physicians in primary care with research experience seem reasonable.
A large number of respondents is a strength of this study. However, the low response rate is an apparent limitation, affecting the generalizability of the results. In general, however, the response rate tends to be low in questionnaire studies of physicians [19]. To maximize the response rate, we kept the number of questions limited, used predefined answers, and sent several reminders. On the other hand, predefined multiple-choice answers may be considered a limitation. Although they were phrased by knowledgeable researchers, it cannot be excluded that relevant aspects were left out. The free-text response options may, to some extent, compensate for this issue, but the threshold to respond to such questions is probably higher. Although performed in five Swedish regions, it may also be regarded as a limitation that our study was restricted to Sweden. Indeed, international comparisons could add valuable insights.
Conclusion
This study confirms that physicians often use drug information sources in professional work, in particular those who work in primary health care. Credibility and easy access online were key factors for usage, and pharmacotherapy and adverse drug reactions were the most common issues. For physicians in primary care, personal factors, such as juniority and sex, were associated with usage and preferences of drug information sources.
Availability of data and materials
Available upon request from the first author.
References
Daei A, Soleymani MR, Ashrafi-Rizi H, Zargham-Boroujeni A, Kelishadi R (2020) Clinical information seeking behavior of physicians: a systematic review. Int J Med Inform 139:104144. https://doi.org/10.1016/j.ijmedinf.2020.104144
Williams JR, Hensel PJ (1991) Changes in physicians’ sources of pharmaceutical information: a review and analysis. J Health Care Mark 11(3):46–60
van der Keylen P, Tomandl J, Wollmann K, Möhler R, Sofroniou M, Maun A, Voigt-Radloff S, Frank L (2020) The online health information needs of family physicians: systematic review of qualitative and quantitative studies. J Med Internet Res 22(12):e18816. https://doi.org/10.2196/18816
McGettigan P, Golden J, Fryer J, Chan R, Feely J (2001) Prescribers prefer people: the sources of information used by doctors for prescribing suggest that the medium is more important than the message. Br J Clin Pharmacol 51(2):184–189. https://doi.org/10.1111/j.1365-2125.2001.01332.x
Alanazi MA, Tully MP, Lewis PJ (2016) A systematic review of the prevalence and incidence of prescribing errors with high-risk medicines in hospitals. J Clin Pharm Ther 41(3):239–245. https://doi.org/10.1111/jcpt.12389
Lazarou J, Pomeranz BH, Corey PN (1998) Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 279(15):1200–5. https://doi.org/10.1001/jama.279.15.1200
Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, Farrar K, Park BK, Breckenridge AM (2004) Adverse drug reactions as cause of admission to hospital: prospective analysis of 18,820 patients. BMJ 329(7456):15–9. https://doi.org/10.1136/bmj.329.7456.15
Clarke MA, Belden JL, Koopman RJ, Steege LM, Moore JL, Canfield SM, Kim MS (2013) Information needs and information-seeking behaviour analysis of primary care physicians and nurses: a literature review. Health Info Libr J 30(3):178–190. https://doi.org/10.1111/hir.12036
Kosteniuk JG, Morgan DG, D’Arcy CK (2013) Use and perceptions of information among family physicians: sources considered accessible, relevant, and reliable. J Med Libr Assoc 101(1):32–37. https://doi.org/10.3163/1536-5050.101.1.006
Axelsson MA, Spetz M, Mellén A, Wallerstedt SM (2008) Use of and attitudes towards the prescribing guidelines booklet in primary health care doctors. BMC Clin Pharmacol 8:8. https://doi.org/10.1186/1472-6904-8-8
Shabi IN, Shabi OM, Akewukereke MA, Udofia EP (2011) Physicians utilisation of internet medical databases at the tertiary health institutions in Osun State, south west. Nigeria Health Info Libr J 28(4):313–320. https://doi.org/10.1111/j.1471-1842.2011.00962.x
Hughes GJ, Patel P, Mason C (2015) Medical resident choices of electronic drug information resources. J Pharm Pract 28(3):280–283. https://doi.org/10.1177/0897190014544820
Mikalef P, Kourouthanassis PE, Pateli AG (2017) Online information search behavior of physicians. Health Info Libr J 34(1):58–73. https://doi.org/10.1111/hir.12170
Skoglund I, Björkelund C, Mehlig K, Gunnarsson R, Möller M (2011) GPs’ opinions of public and industrial information regarding drugs: a cross-sectional study. BMC Health Serv Res 11:204. https://doi.org/10.1186/1472-6963-11-204
Carlzon D, Gustafsson L, Eriksson AL, Rignér K, Sundström A, Wallerstedt SM (2010) Characteristics of primary health care units with focus on drug information from the pharmaceutical industry and adherence to prescribing objectives: a cross-sectional study. BMC Clin Pharmacol 10:4. https://doi.org/10.1186/1472-6904-10-4
Hussein N, Musa S, Stergachis A, Wabe NT, Suleman S (2013) Drug information: prescribers’ need for and access to drug information resources in Ethiopia. Ther Innov Regul Sci 47(2):219–225. https://doi.org/10.1177/2168479012460758
Bernard E, Arnould M, Saint-Lary O, Duhot D, Hebbrecht G (2012) Internet use for information seeking in clinical practice: a cross-sectional survey among French general practitioners. Int J Med Inform 81(7):493–499. https://doi.org/10.1016/j.ijmedinf.2012.02.001
Le JV, Pedersen LB, Riisgaard H, Lykkegaard J, Nexøe J, Lemmergaard J, Søndergaard J (2016) Variation in general practitioners’ information-seeking behavior - a cross-sectional study on the influence of gender, age and practice form. Scand J Prim Health Care 34(4):327–335. https://doi.org/10.1080/02813432.2016.1249057
Cunningham CT, Quan H, Hemmelgarn B, Noseworthy T, Beck CA, Dixon E, Samuel S, Ghali WA, Sykes LL, Jetté N (2015) Exploring physician specialist response rates to web-based surveys. BMC Med Res Methodol 15:32. https://doi.org/10.1186/s12874-015-0016-z
Acknowledgements
We would like to thank administrative personnel in the different regions for helping us with the e-mail addresses. We would also like to thank the Research and Development unit of Region Västerbotten for funding and Maria Bergh, primary care physician, and her colleagues for their help validating the questionnaire.
Funding
Open access funding provided by Umea University. We did not receive funding from any companies, only from the Research and Development Unit of Region Västerbotten.
Author information
Authors and Affiliations
Contributions
Anders Kling launched the idea of the study. Pia Seidel and Anders Kling prepared the design in general with advice from Bo Rolander, Staffan Hägg, Susanna M Wallerstedt, Anna Eriksson, and Ulf Lindahl. Material preparation, data collection, and analysis were performed by Pia Seidel, Anders Kling, and Bo Rolander. The first draft of the manuscript was written by Pia Seidel in collaboration with Anders Kling. Susanna M Wallerstedt, Staffan Hägg, Bo Rolander, Anna Eriksson, and Ulf Lindahl commented and/or contributed with changes to the text in the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Ethical approval
The Swedish Ethical Review Authority determined that the Ethics Review Act was not applicable to this study and had no objections to the performance of the study (ref 2016/157–31). The respondents of the questionnaire stayed anonymous by automatic coding of the questionnaires within esMaker. Thus, no one, including the researchers, could link participants’ responses with their identity.
Consent to participate
Not applicable.
Consent for publication
Not applicable.
Competing interests
No one of the authors has declared competing interest except for Anna L Eriksson, who is an employee at AstraZeneca as of June 20, 2022.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Seidel, P., Rolander, B., Eriksson, A.L. et al. Drug information sources in professional work—a questionnaire study on physicians’ usage and preferences (the drug information study). Eur J Clin Pharmacol 79, 767–774 (2023). https://doi.org/10.1007/s00228-023-03494-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00228-023-03494-4